See Family Practice News, 12/2013, p. 40.
Tuesday, April 8, 2014
Task Force Calls for True Preventive Medicine
The U.S.
Preventive Services Task Force has called for more emphasis on preventive
medicine that can make a difference in patients’ lives, including screening for
cognitive impairment, mental and physical well-being, fall prevention, vision
and hearing problems, and avoiding unintended harms from medical procedures and
testing. One could easily add side
effects from drugs to the list. At COHA,
we have added the specific measures of toxic metals testing, breast
thermography, balance testing, vascular screening (the CHAS score), and the
3-day intensive treatment for eye diseases.
We believe that true prevention is far more effective than vaccines and
screening for diseases that are already present.
Thursday, April 3, 2014
Walking Program Relieves Pain for Breast Cancer Patients
A 6-week
walking program relieved joint pain, fatigue, and stiffness for breast cancer
patients on hormone therapy such as tamoxaphen.
Patients in the program gradually increased their time spent walking by
62 minutes per week. Once again,
exercise works better than almost any drug.
See Family Practice News, 12/2013, p. 20-21. Celebration of Health Associationwebsite
Thursday, March 27, 2014
Dramatic Changes in Fibromyalgia Guidelines
Multispecialty
panels of physicians in Canada, Israel, and Germany have simultaneously made
changes in the diagnosis and treatment of fibromyalgia. Previous focusing on specific tender points
and pain medications has not been successful.
Instead they recommend a diagnosis based on a cluster of symptoms. The 3 medications currently approved to treat
FM (Lyrica, Cymbalta, and Savella) are only mildly successful and can cause
significant side effects. Instead, new
emphasis is placed on alternative therapies such as exercise, tai chi, guided
imagery, acupuncture, spa therapy, naltrexone and hyperbaric oxygen. This is a big step in the right direction.
See Family Practice News, 12/2013, p. 19. Celebration of Health Association website
Tuesday, March 25, 2014
New Guidelines for Weight Loss
The Obesity
Society has issued new guidelines for the management of overweight and obesity
to help doctors and patients achieve successful weight loss. Body Mass Index and waist circumference
appear to be the best indicators for cardiovascular risk, diabetes and
all-cause mortality. No one diet was
recommended, but reduced calories and patient preference were important
factors. The guidelines did not discuss
food allergies, HCG, or herbal reduction of cravings. But they did include the one drug that is
approved for weight loss (Orlistat, which blocks the absorption of fat) and
bariatric surgery. Support groups and
counseling for 6-12 months are helpful for many patients.
See Family Practice News, December 13, 2013, p. 13.
Thursday, March 20, 2014
Risk Calculator Changes Cholesterol Guidelines
The
American College of Cardiology and the American Heart Association have
radically changed the approach to cholesterol levels, which is good and
not-so-good. It is now recommended that
everyone takes a questionnaire that estimates his or her 10-year and lifetime
risk for having a heart attack or stroke.
Then the patient chooses the risk factors that he can modify to reduce
the risk. The good part is the recognition
that there are many risk factors other than cholesterol for vascular
disease. The bad parts are that no one
agrees on what should be on the risk factor list, and that this approach might
greatly expand the number of people that are put on statin drugs with minimal
benefit.
Google the Framingham Risk Analysis or go to the Chappell
Heart Alzheimer’s Stroke Score (CHAS) score, which will soon appear on
healthcelebration.com.
Tuesday, March 18, 2014
Is Testosterone Treatment for Men Safe?
There has
been a flood of advertising about treatment of men with “low T”. There is little doubt that some men feel
better if their blood testosterone is low and they are treated with the
hormone. However, there might be a
slight increase in the risk for heart attacks in patients that have been
treated with synthetic testosterone.
With the limited evidence we have at this time, it would be advisable to
first try natural approaches, such as supplements to raise nitric oxide. If testosterone is prescribed, bio-identical
hormone replacement might be preferable.
See JAMA, Nov. 6; 310: 1805.
Tuesday, March 11, 2014
Comparing the Impact of a Mediterranean Diet to Chelation Therapy in Diabetic Patients
One of the
most publicized studies in 2013 was a 5-year Spanish clinical trial that
compared the Mediterranean diet with or without extra olive oil and nuts to a
low fat diet in diabetics and those with high risk factors for diabetes. There was a slight reduction in cardiac
events, but they had to treat 70 patients for 5 years to prevent one event. The
TACT study of chelation therapy showed that you only had to treat 7 patients to
prevent one cardiac event over 5 years.
According to chief investigator, Dr. Lamas, the impact of chelation
therapy appears to be greater than any other single intervention to treat
diabetes.
See the NEJM Journal Watch, year in review for 2013, the
factoral analysis for TACT is in press to be published in the American Heart
Journal.
Subscribe to:
Posts (Atom)